The US biosimilar market: Predictions for 2021
pharmaphorum
JANUARY 28, 2021
As we’ve seen over those five years, biosimilars are critical in continuing to provide doctors and patients choice in their care plans as well as continuing to decrease overall healthcare costs. One of these markets is the insulin market. Americans pay ten times as much for insulin as Canadian patients do.
Let's personalize your content